Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease

TheScientificWorldJournal

Volumn 2012, Issue , 2012, Pages

  Ji, Hong Fang ^a   Shen, Liang ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BERBERINE; CHOLINESTERASE; ISOLEUCINE; PHENYLALANINE; TRYPTOPHAN; TYROSINE; AMINE OXIDASE (FLAVIN CONTAINING);

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG STRUCTURE; ENZYME INHIBITION; HYDROGEN BOND; MOLECULAR DOCKING; SIMULATION; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DESIGN; ENZYMOLOGY;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; BERBERINE; BUTYRYLCHOLINESTERASE; DRUG DESIGN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MONOAMINE OXIDASE;

EID: 84856389055     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/823201     Document Type: Article

References (30)

1. Imanshahidi M., Hosseinzadeh H., Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine Phytotherapy Research 2008 22 8 999 1012
2. Vuddanda P. R., Chakraborty S., Singh S., Berberine: a potential phytochemical with multispectrum therapeutic activities Expert Opinion on Investigational Drugs 2010 19 10 1297 1307
3. Kuo C. L., Chi C. W., Liu T. Y., The anti-inflammatory potential of berberine in vitro and in vivo Cancer Letters 2004 203 2 127 137
4. Sun Y., Xun K., Wang Y., Chen X., A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs Anti-Cancer Drugs 2009 20 9 757 769
5. Rakov L., Mjekov M., Kot'lov D., tefek M., Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifolium. Structural aspects Bioorganic Medicinal Chemistry 2004 12 17 4709 4715
6. Stermitz F. R., Lorenz P., Tawara J. N., Zenewicz L. A., Lewis K., Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5-methoxyhydnocarpin, a multidrug pump inhibitor Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1433 1437 (Pubitemid 30118458)
7. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E., Alzheimer's disease The Lancet 2011 377 9770 1019 1031
8. Holtzman D. M., Morris J. C., Goate A. M., Alzheimer's disease: the challenge of the second century Science Translational Medicine 2011 3 77 77sr1
9. Cummings J. L., Alzheimer's disease The New England Journal of Medicine 2004 351 1 56 57
10. Plassman B. L., Langa K. M., Fisher G. G., Heeringa S. G., Weir D. R., Ofstedal M. B., Burke J. R., Hurd M. D., Potter G. G., Rodgers W. L., Steffens D. C., Willis R. J., Wallace R. B., Prevalence of dementia in the United States: the aging, demographics, and memory study Neuroepidemiology 2007 29 1-2 125 132 (Pubitemid 350191430)
11. Zhu F., Qian C., Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease BMC Neuroscience 2006 7, article 78
12. Ji H-F., Shen L., Berberine: a potential multipotent natural product to combat Alzheimer's disease Molecules 2011 16 8 6732 6740
13. Ye M., Fu S., Pi R., He F., Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research Journal of Pharmacy and Pharmacology 2009 61 7 831 837
14. Jung H. A., Min B. S., Yokozawa T., Lee J. H., Kim Y. S., Choi J. S., Anti-Alzheimer and antioxidant activities of coptidis rhizoma alkaloids Biological Pharmaceutical Bulletin 2009 32 8 1433 1438
15. Ingkaninan K., Phengpa P., Yuenyongsawad S., Khorana N., Acetylcholinesterase inhibitors from Stephania venosa tuber Journal of Pharmacy and Pharmacology 2006 58 5 695 700
16. Huang L., Luo Z., He F., Shi A., Qin F., Li X., Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase Bioorganic Medicinal Chemistry Letters 2010 20 22 6649 6652
17. Huang L., Shi A., He F., Li X., Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors Bioorganic Medicinal Chemistry 2010 18 3 1244 1251
18. Kim D. K., Lee K. T., Baek N. I., Kim S. H., Park H. W., Lim J. P., Shin T. Y., Eom D. O., Yang J. H., Eun J. S., Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa Archives of Pharmacal Research 2004 27 11 1127 1131
19. Kong L. D., Cheng C. H. K., Tan R. X., Monoamine oxidase inhibitors from rhizoma of Coptis chinensis Planta Medica 2001 67 1 74 76 (Pubitemid 32199950)
20. Lee S. S., Kai M., Lee M. K, Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: inhibition by berberine and palmatine Medical Science Research 1999 27 11 749 751 (Pubitemid 29535079)
21. Castillo J., Hung J., Rodriguez M., Bastidas E., Laboren I., Jaimes A., LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation Analytical Biochemistry 2005 343 2 293 298 (Pubitemid 41074043)
22. Kulkarni S. K., Dhir A., On the mechanism of antidepressant-like action of berberine chloride European Journal of Pharmacology 2008 589 13 163 172
23. Dvir H., Jiang H. L., Wong D. M., Harel M., Chetrit M., He X. C., Jin G. Y., Yu G. L., Tang X. C., Silman I., Bai D. L., Sussman J. L., X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement Biochemistry 2002 41 35 10810 10818 (Pubitemid 34971058)
24. Nicolet Y., Lockridge O., Masson P., Fontecilla-Camps J. C., Nachon F., Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products The Journal of Biological Chemistry 2003 278 42 41141 41147 (Pubitemid 37280939)
25. Ma J., Yoshimura M., Yamashita E., Nakagawa A., Ito A., Tsukihara T., Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors Journal of Molecular Biology 2004 338 1 103 114 (Pubitemid 38429789)
26. Binda C., Newton-Vinson P., Hublek F., Edmondson D. E., Mattevi A., Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders Nature Structural Biology 2001 9 1 22 26
27. Jain A. N., Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine Journal of Medicinal Chemistry 2003 46 4 499 511 (Pubitemid 36182752)
28. Kellenberger E., Rodrigo J., Muller P., Rognan D., Comparative evaluation of eight docking tools for docking and virtual screening accuracy Proteins 2004 57 2 225 242 (Pubitemid 39223729)
29. Holt P. A., Chaires J. B., Trent J. O., Molecular docking of intercalators and groove-binders to nucleic adds using autodock and surflex Journal of Chemical Information and Modeling 2008 48 8 1602 1615
30. Yang M., Zhou L., Zuo Z., Tang X., Liu J., Ma X., Structure-based virtual screening for glycosyltransferase51 Molecular Simulation 2008 34 9 849 856